Greenwich LifeSciences
Stock Forecast, Prediction & Price Target
Greenwich LifeSciences Financial Estimates
Greenwich LifeSciences Revenue Estimates
Greenwich LifeSciences EBITDA Estimates
Greenwich LifeSciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-4.54M N/A | $-7.61M -67.50% | $-8.89M -16.84% | Avg: $-8.99M Low: $-8.99M High: $-8.99M avg. -1.14% | |||
EBITDA
% change YoY
| $-4.59M N/A | $-8.03M -74.92% | $-9.32M -16.02% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$0.35 N/A | -$0.59 -68.57% | -$0.69 -16.94% | Avg: -$0.7 Low: -$0.7 High: -$0.7 avg. -1.44% | |||
Operating Expenses
% change YoY
| $4.59M N/A | $8.04M 74.86% | $9.32M 16.01% | Avg: $0 Low: $0 High: $0 avg. -100% |
FAQ
What is Greenwich LifeSciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -1.14% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -8.99M, average is -8.99M and high is -8.99M.
What is Greenwich LifeSciences stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Greenwich LifeSciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -1.44% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.7, average is -$0.7 and high is $-0.7.